Stock analysts at Zacks Research decreased their Q1 2025 earnings estimates for shares of Thermo Fisher Scientific in a research report issued to clients and investors on Thursday, February 20th.

Biopharmaceutical CMO Market Rapid outsourcing trends and robust investments in advanced manufacturing drive the biopharmaceutical CMO mark ...

President Donald Trump reignited global trade tensions by announcing a 25% tariff on all imported steel and aluminum. This ...

Gene Editing Tool Market AnalysisThe global gene editing tool market is on the cusp of a revolutionary expansion, projected to grow at an impressive CAGR of 18.4% from 2024 to 2034. Valued at USD 688.

Foreign investments in Flanders created 5,000 new jobs in 2024, with the United States accounting for 21.6% of total projects, including a strong presence in the pharmaceutical and biotech sectors.

Ethylene carbonate, a cyclic organic compound, is a key component in lithium-ion batteries and various chemical applications. As industries pivot towards sustainable and efficient solutions, the ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

Berlin-headquartered naturalX Health Ventures is a new fund that will invest in some of Europe's fastest-growing consumer ...

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...

Waters earned more than half of its revenue in 2024 from markets in Asia and Europe. Typically, a stronger dollar eats ...

Ken Fisher is the founder and executive chairman of Fisher Asset Management, a renowned investment and financial analysis ...